IRIS Accounts Production v24.3.2.46 04549018 director 1.11.23 31.10.24 31.10.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh045490182023-10-31045490182024-10-31045490182023-11-012024-10-31045490182022-10-31045490182022-11-012023-10-31045490182023-10-3104549018ns15:EnglandWales2023-11-012024-10-3104549018ns14:PoundSterling2023-11-012024-10-3104549018ns10:Director12023-11-012024-10-3104549018ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3104549018ns10:SmallEntities2023-11-012024-10-3104549018ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3104549018ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3104549018ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3104549018ns10:AbridgedAccounts2023-11-012024-10-310454901812023-11-012024-10-3104549018ns10:CompanySecretary12023-11-012024-10-3104549018ns10:RegisteredOffice2023-11-012024-10-3104549018ns5:CurrentFinancialInstruments2024-10-3104549018ns5:CurrentFinancialInstruments2023-10-3104549018ns5:ShareCapital2024-10-3104549018ns5:ShareCapital2023-10-3104549018ns5:RetainedEarningsAccumulatedLosses2024-10-3104549018ns5:RetainedEarningsAccumulatedLosses2023-10-3104549018ns5:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3104549018ns5:PlantMachinery2023-11-012024-10-3104549018ns5:FurnitureFittings2023-11-012024-10-3104549018ns5:ComputerEquipment2023-11-012024-10-31
REGISTERED NUMBER: 04549018 (England and Wales)











Unaudited Financial Statements

for the Year Ended 31st October 2024

for

Dyffryn Pharmacy Limited

Dyffryn Pharmacy Limited (Registered number: 04549018)






Contents of the Financial Statements
for the year ended 31st October 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Dyffryn Pharmacy Limited

Company Information
for the year ended 31st October 2024







DIRECTOR: Mrs M D Littlewood



SECRETARY: P G Littlewood



REGISTERED OFFICE: Castle House
High Street
Ammanford
Carmarthenshire
SA18 2NB



REGISTERED NUMBER: 04549018 (England and Wales)



ACCOUNTANTS: Ashmole & Co
Chartered Certified Accountants
Castle House
High Street
Ammanford
Carmarthenshire
SA18 2NB



BANKERS: Barlays Bank plc
30 St Teilo Street
Pontarddulais
Swansea
SA4 1SZ

Dyffryn Pharmacy Limited (Registered number: 04549018)

Abridged Balance Sheet
31st October 2024

31.10.24 31.10.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 8,605 11,428
8,605 11,428

CURRENT ASSETS
Stocks 22,121 30,233
Debtors 130,011 119,193
Cash at bank and in hand 49,446 80,408
201,578 229,834
CREDITORS
Amounts falling due within one year 66,767 76,429
NET CURRENT ASSETS 134,811 153,405
TOTAL ASSETS LESS CURRENT
LIABILITIES

143,416

164,833

PROVISIONS FOR LIABILITIES 1,554 2,091
NET ASSETS 141,862 162,742

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 141,861 162,741
SHAREHOLDERS' FUNDS 141,862 162,742

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st October 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dyffryn Pharmacy Limited (Registered number: 04549018)

Abridged Balance Sheet - continued
31st October 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31st October 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 4th March 2025 and were signed by:





Mrs M D Littlewood - Director


Dyffryn Pharmacy Limited (Registered number: 04549018)

Notes to the Financial Statements
for the year ended 31st October 2024

1. STATUTORY INFORMATION

Dyffryn Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on cost
Fixtures and fittings - 15% on cost
Computer equipment - 15% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Dyffryn Pharmacy Limited (Registered number: 04549018)

Notes to the Financial Statements - continued
for the year ended 31st October 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 5 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1st November 2023
and 31st October 2024 35,000
AMORTISATION
At 1st November 2023
and 31st October 2024 35,000
NET BOOK VALUE

At 31st October 2024 -
At 31st October 2023 -

Dyffryn Pharmacy Limited (Registered number: 04549018)

Notes to the Financial Statements - continued
for the year ended 31st October 2024

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1st November 2023
and 31st October 2024 101,668
DEPRECIATION
At 1st November 2023 90,240
Charge for year 2,823
At 31st October 2024 93,063
NET BOOK VALUE
At 31st October 2024 8,605
At 31st October 2023 11,428